DRUGS

  1. The 6 S's of a psychedelic journey - Set - Setting - Substance - Sitter - Session - Situation

    Adapted From Chapter 19 of The Psychedelic Explorer’s Guide by Jim Fadiman If you have any familiarity with LSD use, you’ve probably heard the expression “Set and Setting.” It was coined by Norman Zinberg to describe the context for psychedelic drug experience and has become widely accepted by researchers in psychedelic therapy. Unknown to most others, however, are four other S’s: substance, sitter, session, and situation. Although these four S’s do not play as primary a role as Set and...
  2. Underground MDMA-, LSD- and 2-CB-assisted individual and group psychotherapy in Zurich

    Underground MDMA-, LSD- and 2-CB-assisted individual and group psychotherapy in Zurich: Outcomes, implications and commentary Ben Sessa and Friederike Meckel Fischer Abstract Underground psychedelic-assisted psychotherapy has persisted in Europe despite the banning of the substances LSD and MDMA in the 1960s and 1980s, respectively. This article describes the work of a Zurich-based psychotherapist providing individual and group psycholytic psychotherapy, whose practice persisted for several...
  3. Long-term systemic treatment with lysergic acid diethylamide causes retinal damage in CD1 mice

    As a classical hallucinogen with high potential for abuse, lysergic acid diethylamide (LSD) can cause long-lasting abnormalities in retina, but little is known about the exact mechanism. This study was to investigate effects of long-term systemic treatment of LSD at low dose on retinal damage and understand the underlying mechanisms. CD1 mice were treated intraperitoneally with 0.1 mg/kg or 0.2 mg/kg LSD daily for 2 months, mice treated with saline as negative control. Electroretinography...
  4. Ultimate Kratom Tea Recipe Discovered By The Drugs Forum Chancellor Of Space Drugs

    After numerous trials and tribulations, the Drugs Forum Chancellor of Space Drugs has discovered the perfect Kratom Tea recipe. The recipe simply requires 1 pot, water, 4 packs of hot cocoa, lemon juice, 10-15 grams of Kratom (preferably red vein Borneo or Bali if you want to get super relaxed), a stirring spoon, a metal coffee filter aka permanent coffee filter, and a cup big enough that you can put the metal coffee filter into it. ***Please do not skip the permanent coffee filter, trying...
  5. Treatment of Childhood Schizophrenia Utilizing LSD and Psilocybin

    From the Newsletter of the Multidisciplinary Association for Psychedelic Studies MAPS - Volume 7 Number 3 Summer 1997 - pp. 18-25 Treatment of Childhood Schizophrenia Utilizing LSD and Psilocybin Gary Fisher, Ph.D. Now that the FDA has permitted research with LSD and psilocybin to resume, we feel it is important to share examples of a remarkable experiment, the results of which were not sufficiently taken into account because this line of research was prematurely halted in the...
  6. The comeback of psychedelic science

    Psychedelic science is making a comeback. Scientific publications, therapeutic breakthroughs and cultural endorsements suggest that the historical reputation of psychedelics —such as lysergic acid diethylamide (LSD), mescaline (from the peyote cactus) and psilocybin (mushrooms) —as dangerous or inherently risky have unfairly overshadowed a more optimistic interpretation. Recent publications, like Michael Pollan's How to Change your Mind, showcase the creative and potentially therapeutic...
  7. A case report “A Physician’s Attempt to Self-Medicate Bipolar Depression with DMT

    Journal name: Journal of Psychoactive Drugs Here’s what happened when a psychiatrist tried to treat his depression by smoking DMT every day By Eric W. Dolan July 9, 2017 A case report recently published in the Journal of Psychoactive Drugs chronicles the story of a 40-year-old retired male psychiatrist who tried to treat his bipolar disorder using a powerful psychedelic drug called N,N-dimethyltryptamine (DMT). DMT was first synthesized by the chemist Richard H. F. Manske in 1931....
  8. Here's why we must continue to study Kratom and other opioid-like drugs

    The Hill, published July 8, 2018 by Paula N. Brown The U.S. Food and Drug Administration (FDA) recently gave final approval for the first non-opioid drug shown to lessen the severity of opioid withdrawal symptoms. Meanwhile, President Trump signed into law groundbreaking “right to try” legislation allowing the terminally ill to explore unapproved medical treatments as a last resort. In light of these developments, researchers and advocates of the botanical Kratom were hopeful for increased...
  9. Magic mushrooms may help with depression, say leading scientists

    Active ingredient could allow sufferers to relive happier times, says team including former government adviser David Nutt Magic mushrooms' active ingredient psilocybin enables users to experience more vivid recollections. Photograph: Peter Dejong/AP A drug derived from magic mushrooms could help people with depression by enabling them to relive positive and happy moments of their lives, according to scientists including the former government drug adviser, Professor David Nutt. Two studies,...
  10. Could LSD be the newest treatment for depression?

    Serotonin pathways activated by hallucinogens parallel those of antidepressants According to a study at the University of Basel, lysergic acid diethylamide, or “LSD,” a psychedelic drug, could be used as a form of treatment for depression and other mood disorders. Although current research on the underlying mechanisms of hallucinogens like LSD is lacking, recent findings show that it interferes with serotonin — a neurotransmitter related to mood and appetite regulation — much like common...
  11. Blue Bruising & Psilocybin Mushrooms

    Blue bruising is one of the most famous features of psilocybin containing mushrooms. Blue bruising (along with two other features) provides strong evidence that a particular mushroom is an active psilocybin mushroom. The complete 3-part test for identifying an active psilocybin mushroom is as follows: The mushroom bruises bluish; The mushroom deposits a purple-brown spore print; and The mushroom has a semi-gelatinous separable pellicle. Blue bruising of psilocybe azurescens – note the blue...
  12. Cannabis and ADHD/ADD

    [URL]https://www.leafly.com/news/health/cannabis-and-addadhd[/URL] In the eyes of popular culture, cannabis consumers aren’t exactly models of concentration and cognitive performance. So when a small group of researchers began exploring cannabis as alternative treatment for attention deficit disorders, there was of course some scoffing and skepticism. Nevertheless, with so many medical marijuana patients swearing by its ability to promote focus in place of prescription stimulants, these doctors sought...
  13. Does Cannabis Do Anything For ADHD?

    [URL]http://adhdboss.com/cannabis-adhd/[/URL] Most people with ADHD have smoked weed at one point or another. But, does cannabis actually do anything for ADHD? Or…is using cannabis just another way to get high, and kill time? Well, this article explains the pros and cons of using cannabis for ADHD. Plus, towards the end of this article, I give you one little recommendation that could change the way that you think about cannabis forever. So, let’s get started with the potential medicinal benefits...
  14. Medical marijana review: Harlequin

    Marijuana Harlequin Strain Review Strains Contents Strain name info: Harlequin Marijuana Strain Our Overall Rating: 4.7 / Best known for: High CBD content Positive Effects Origin / ancestry Harlequin Type: Harlequin is a hybrid of the following strains: · Columbian Gold · Thai Sativa · Nepali Indica · Swiss Sativa Harlequin is gentle giant of a hybrid. It has CBD levels of 10 t0 15%. Its genetics are mixed in precise amounts to produce a medical...
  15. ADHD Patients Successfully Treated with Cannabis

    [URL]https://hightimes.com/culture/adhd-patients-successfully-treated-cannabis/[/URL] The use of herbal cannabis eases symptoms in adults suffering from ADHD (attention deficiency hyperactivity disorder), according to clinical trial data presented at an international symposium on cannabinoid therapeutics last month. German researchers evaluated the effects of marijuana in 30 patients suffering from ADHD. All of the subjects participating in the trial had previously tried various forms of conventional...
Loading...